Business Wire

PA-BENTLEY-SYSTEMS

23.3.2021 15:04:01 CET | Business Wire | Press release

Share
Bentley Acceleration Initiatives Launches OpenTower iQ, a Digital Co-Venture with Visual Intelligence and Aeroprotechnik for 5G Towers

Bentley Acceleration Initiatives today announced the availability of OpenTower® iQ , a digital twin solution “powered by iTwin” for telecom towers that provides 3D visualization, real-time decision support, and predictive design from the ground up. OpenTower iQ is the result of a digital co-venture between Bentley and Visual Intelligence, a Houston, Texas-based sensor technology company, and Aeroprotechnik, an aerial inspection engineering company based in Viseu, Portugal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005733/en/

Bentley Acceleration Initiatives is Bentley Systems’ (Nasdaq: BSY) strategic investment fund and incubator initiative. Its objective is to bring together ecosystem partners in a digital co-ventures to accelerate the go-to-market of creative cloud solutions based on the Bentley iTwin platform. OpenTower iQ , ‘powered by iTwin,’ is a textbook example of co-venturing that combines innovative digital technologies from entrepreneurial companies to address a market need in double-quick time.

As the demand for data continues to grow, tower companies and engineering firms are looking for all-inclusive, engineering-grade solutions to co-locate, modify, and maintain telecom infrastructure for the 5G rollout. OpenTower iQ makes it easy to modify existing towers and maintain accurate models, automating the repetitive work of producing as-built models and using artificial intelligence to detect critical components.

Tower companies can use OpenTower iQ to monitor the health of their towers and gain access to shared, secured data through an easy-to-understand portal. Data analytics provide cost benefit analysis to boost operational efficiency and revenue assurance. Improved accuracy of tower inspections and smart inventory management saves time, cost, and improves safety. OpenTower iQ is designed to handle the large asset portfolios of operators, easily processing and analyzing tens of thousands of towers.

Combines artificial intelligence and patented drone technologies

To accelerate the launch of OpenTower iQ , Bentley Acceleration Initiatives acquired digital twin technology from Aeroprotechnik, a leading aerial inspection engineering company that specializes in automated asset data capture and digitalization solutions. The technology included artificial intelligence and reality modeling capabilities that provide detailed information on current site conditions, which helps tower companies speed up rollouts, enhance decision-making, and shorten sales cycles.

Bentley Acceleration Initiatives also partnered with Visual Intelligence whose patented dual-sensor drone technology digitalizes physical infrastructure with millimeter accuracy to reliably deliver 3D, engineering-grade asset intelligence. Visual Intelligence is able to map more measurable surface area than alternative aerial and ground-based methods. Its patented drone sensor technology has the unique ability to capture the components of a tower including bolts, wires, ladders, and other items with an extremely high degree of accuracy that was not previously possible.

Now, with a comprehensive millimeter accurate digital twin, a tower company can virtually inspect their tower, see if it has been constructed correctly, determine if the tower’s structural integrity is intact, and run co-location scenarios. Unlike rudimentary reality models produced from other cameras, Visual Intelligence enables a digital twin with such accuracy that it can support advanced analyses such as connection integrity analysis and mount mapping analysis.

“The objective of Bentley Acceleration Initiatives is to incubate new businesses and augment existing ones using Bentley iTwin technologies. We provide a go-to-market accelerator to rapidly bring to users the innovative ideas from Bentley’s research and development in partnership with emerging industry leaders and technology specialists such as Visual Intelligence and Aeroprotechnik. Bentley Acceleration Initiatives helped incubate OpenTower iQ by funding its development, seeking out technology partnerships to fill whitespaces, and creating a comprehensive go-to-market strategy,” said Santanu Das, senior vice president, chief acceleration officer, Bentley Acceleration Initiatives. “Our next step is to invite additional interested ecosystem partners to kick start new digital integrator services to capture huge emerging opportunities for enterprise integration and implementation for towers. The telecom industry is going through a rapid transformation as multinetwork operators are expanding their portfolios through consolidation and moving from a 4G platform to 5G. Without a doubt, digital twin solutions like OpenTower iQ , ‘powered by iTwin,’ will help tower owners make the most of the industry’s burgeoning opportunities.”

OpenTower iQ for tower planning and management is a game changer for the telecom market. Within a couple of days, we had a high-quality reality model available with the reports and other aspects of the projects. Now, all the tower data is available in digital form—and it’s accurate and current,” said Nikhil Jani, vice president, telecom and utilities, Genesys International.

“Until now, drone data has failed to live up to its promise to the tower industry. This is largely because survey-grade drone sensors can’t collect the fidelity of data required to extract engineering-grade tower intelligence. Our patented drone sensor technology is the first of its kind to collect millimeter-class tower information. We partnered with Bentley to utilize OpenTower iQ to translate this new fidelity of data into as-built digital twins, and then apply AI to automate and unlock new kinds of tower insights. With OpenTower iQ , we’re enabling new applications of drone data and accelerating the value of digital twins to tower companies worldwide,” said Ted Miller, founder and chairman of Visual Intelligence and former chairman and CEO of Crown Castle International (NYSE: CCI).

“Bentley Acceleration Initiatives proved to be an effective platform for ecosystem partners like Aeroprotechnik to scale up artificial intelligence-based solutions, transforming emerging technologies into real value for Bentley’s users,” said Nuno Marques, founder of Aeroprotechnik.

Images and captions:

About Visual Intelligence

Visual Intelligence, based in Houston, Texas, has emerged as an industry-leading software and sensor technology company that delivers geo-imaging solutions for airborne, terrestrial, and mobile applications. It provides the Visual Intelligence unified drone sensor and software automation platform that digitizes physical infrastructure with millimeter accuracy to reliably deliver 3D, engineering-grade asset intelligence. https://visualintelligenceinc.com/telecom/

About Bentley Systems

Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation -based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com www.bentleyaccelerationinitiatives.com . www.opentower.com

© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, OpenTower, OpenTower iQ, and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye